Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Hyperlipidemias

1-methyl-3-isobutylxanthine has been researched along with Hyperlipidemias in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Hyperlipidemias: Conditions with excess LIPIDS in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kishi, Y1
Nishiyama, K1
Numano, F1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Hyperlipidemias

ArticleYear
Cyclic AMP accumulation in rabbit aorta smooth muscle cells altered in the presence of hyperlipidemic serum.
    Atherosclerosis, 1985, Volume: 56, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Aorta, Thoracic;

1985